Dawaa Reference

acute

Acute rheumatic fever without carditis

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources7 sources

MSF Essential Drugs 2024 (ibuprofen oral monograph) · 2015 ESC Guidelines for the diagnosis and management of pericardial diseases, European Society of Cardiology (Eur Heart J 2015;36:2921-64) · DailyMed Ibuprofen Tablet Package Insert (DailyMed, NLM) · Acute rheumatic fever without carditis - disease-level clinical article (acute-rheumatic-fever-without-carditis-full.txt) · Acute Rheumatic Fever - disease-level clinical article (acute-rheumatic-fever-without-carditis-clinical.txt) · Egyptian National Drug Formulary - Antimicrobial 2023 · Egyptian National Drug Formulary - Endocrine System 2024 (prednisolone monograph)

Verified against6 documents
  • MSF Essential Drugs 2024 (ibuprofen oral monograph)
  • DailyMed Ibuprofen Tablet Package Insert (DailyMed, NLM)
  • Acute Rheumatic Fever - disease-level clinical article (acute-rheumatic-fever-without-carditis-clinical.txt)
  • Egyptian National Drug Formulary - Antimicrobial 2023
  • Acute rheumatic fever without carditis - disease-level clinical article (acute-rheumatic-fever-without-carditis-full.txt)
  • Egyptian National Drug Formulary - Endocrine System 2024 (prednisolone monograph)

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (6)

  • Sore throat two to four weeks before joint symptoms begin, from untreated strep infection [sore throat]
  • Roughly a third of patients cannot recall having had a preceding throat infection
  • General fever, chills, and tiredness affect most patients with the illness [chills · fatigue · fever]
  • Migratory joint aches, usually the earliest complaint, in 60 to 80 percent of cases [joint pain]
  • Sudden irregular jerking movements involving the face, hands, and feet, worse on one side
  • Chorea can bring agitation, anxiety, or bouts of inappropriate laughing or crying [anxiety · chorea · irritability]

Signs — what you find (6)

  • Affected joints look red, swollen, and are markedly tender to touch
  • Firm, painless lumps over joints, mainly on the extensor surfaces
  • A pink ring-shaped rash with raised edges and a clear center on the trunk and limbs, sparing the face [rash]
  • The rash fades from one spot and reappears elsewhere, described as a snake-like, fleeting pattern [rash]
  • Grip strength intermittently gives way when the patient squeezes the examiner's hand, the classic milkmaid finding
  • Facial grimacing, tics, and slurred or poorly formed speech and handwriting can accompany chorea [chorea · tics]

Tests (7)

  • Throat culture is the reference standard for confirming strep, though results take time
  • Rapid strep antigen tests run under 90 percent sensitive, so a negative needs backup culture
  • Antistreptolysin O or anti-DNase B antibody levels climb two to three weeks after the strep infection
  • A doubling of the antibody titer on repeat testing counts as a positive result
  • Every patient needs a cardiac work-up including chest x-ray, ECG, and echocardiogram
  • The ECG most often shows a prolonged PR interval, adjusted for the patient's age
  • Echocardiography can pick up heart involvement that the physical exam misses entirely

If not this — what else fits (8)

  • Lyme disease can mimic the migratory joint pain of ARF
  • Reactive arthritis following a strep infection is a joint-pain mimic
  • Septic arthritis is a joint-involvement mimic to rule out
  • A drug reaction or serum sickness can also cause migratory joint pain
  • PANDAS, a post-strep autoimmune neuropsychiatric syndrome, mimics the chorea of ARF
  • Tourette syndrome is on the differential for the abnormal movements seen in chorea
  • Kawasaki disease overlaps with ARF's rash and systemic features
  • Juvenile idiopathic arthritis and lupus belong on the differential for the systemic picture

SourceStatPearls "Acute Rheumatic Fever" - disease-level clinical article

Presentation findings are traced to the source above.

Rx: Main treatment | Secondary prophylaxis | If aspirin or an NSAID cannot be used

MAIN TREATMENT - choose one

1

IBUPROFEN

1st line

Strength400 mg

Formoral.solid

Adult dose and duration

200 to 400 mg three to four times daily, with or after food. Never more than 1200 mg in a day.

Paediatric dose

5-10 mg/kg/dose [child max 400 mg]

(Child over 3 months: 5 to 10 mg/kg 3 to 4 times daily (max. 30 mg/kg daily).)

Dose by weight
3kg15-30 mg/dose
4kg20-40 mg/dose
5kg25-50 mg/dose
6kg30-60 mg/dose
7kg35-70 mg/dose
8kg40-80 mg/dose
9kg45-90 mg/dose
10kg50-100 mg/dose
11kg55-110 mg/dose
12kg60-120 mg/dose
13kg65-130 mg/dose
14kg70-140 mg/dose
15kg75-150 mg/dose
16kg80-160 mg/dose
17kg85-170 mg/dose
18kg90-180 mg/dose
19kg95-190 mg/dose
20kg100-200 mg/dose
21kg105-210 mg/dose
22kg110-220 mg/dose
23kg115-230 mg/dose
24kg120-240 mg/dose
25kg125-250 mg/dose
26kg130-260 mg/dose
27kg135-270 mg/dose
28kg140-280 mg/dose
29kg145-290 mg/dose
30kg150-300 mg/dose
31kg155-310 mg/dose
32kg160-320 mg/dose
33kg165-330 mg/dose
34kg170-340 mg/dose
35kg175-350 mg/dose
36kg180-360 mg/dose
37kg185-370 mg/dose
38kg190-380 mg/dose
39kg195-390 mg/dose
40kg200-400 mg/dose
41kg205-400 mg/dose (upper capped)
42kg210-400 mg/dose (upper capped)
43kg215-400 mg/dose (upper capped)
44kg220-400 mg/dose (upper capped)
45kg225-400 mg/dose (upper capped)
46kg230-400 mg/dose (upper capped)
47kg235-400 mg/dose (upper capped)
48kg240-400 mg/dose (upper capped)
49kg245-400 mg/dose (upper capped)
50kg250-400 mg/dose (upper capped)
Dose source

MSF Essential Drugs 2024 (ibuprofen oral monograph)

Why

Rheumatic fever polyarthritis needs sustained anti-inflammatory dosing to control joint inflammation, the same scale used for pericarditis, rather than a low symptomatic-relief dose.

Cautions
  • Any new murmur, chest pain, or breathlessness during the illness means carditis may be developing and referral is needed.
  • This is genuine anti-inflammatory dosing for migratory polyarthritis, not a symptomatic pain-relief dose - do not substitute a low PRN dose.
  • Gastroprotection (e.g. a PPI) should be given alongside this dose.
  • Any new murmur, chest pain, or breathlessness during treatment suggests carditis is developing - refer immediately; this course does not replace the secondary antibiotic prophylaxis, which must be arranged separately.
  • Taper rather than stop abruptly as symptoms and inflammatory markers settle.
  • Do not use in children under 12 years of age.
Egyptian brands
Egyptian brandManufacturerIndicative price
DAJUANOFEN 400 MG 20 F.C. TABS.COPAD PHARMA5.00 EGP (0.25/unit)
FLABU 400MG 10 F.C.TAB.DELTA PHARMA3.75 EGP (0.38/unit)
NOVA-PROFEN 400MG 30 F.C. TABLETSSANOFI12.75 EGP (0.42/unit)
IBUPROFEN 400 MG 10 TAB.SEDICO6.00 EGP (0.60/unit)
MAFO 400 MG 30 F.C.TABSEIPICO42.00 EGP (1.40/unit)
BRUFEN 400 MG 30 TABS.KAHIRA > ABBOTT LABORATORIES78.00 EGP (2.60/unit)
PROFUSOL 400MG 20 S.G CAPS.EUROPEAN EGYPTIAN PHARM. IND.31.00 EGP
ANALGIPROF 400 MG 25 SACHETSEVA PHARMA37.50 EGP
NOVA-PROFEN 100MG/5ML ORAL SUSP. 100ML? strength differs? different route - not oral solidSANOFI2.25 EGP
BRUFEMOL-N SUSP. 60 ML? strength differs? different route - not oral solidARAB DRUG COMPANY (ADCO)4.50 EGP
2

REFERRAL & SAFETY-NETTING (NO DRUG THERAPY)

1st line
Dose source

Acute Rheumatic Fever - disease-level clinical article (acute-rheumatic-fever-without-carditis-clinical.txt)

Why

Carries the referral criteria and warning signs for this condition, which apply whichever treatment is chosen.

Cautions
  • RED FLAG - Initial management of acute rheumatic fever should be as an inpatient, including cases without carditis at diagnosis, since carditis can be subclinical and detected only by echocardiography - an outpatient ibuprofen course alone is not enough.
3

ACETYLSALICYLIC ACID

2nd line

Formoral.solid

Adult dose and duration

60 to 100 mg/kg/day in divided doses until symptom resolution

Paediatric dose

60-100 mg/kg/day

(60 to 100 mg/kg/day in divided doses until symptom resolution)

Dose by weight
3kg180-300 mg/day
4kg240-400 mg/day
5kg300-500 mg/day
6kg360-600 mg/day
7kg420-700 mg/day
8kg480-800 mg/day
9kg540-900 mg/day
10kg600-1000 mg/day
11kg660-1100 mg/day
12kg720-1200 mg/day
13kg780-1300 mg/day
14kg840-1400 mg/day
15kg900-1500 mg/day
16kg960-1600 mg/day
17kg1020-1700 mg/day
18kg1080-1800 mg/day
19kg1140-1900 mg/day
20kg1200-2000 mg/day
21kg1260-2100 mg/day
22kg1320-2200 mg/day
23kg1380-2300 mg/day
24kg1440-2400 mg/day
25kg1500-2500 mg/day
26kg1560-2600 mg/day
27kg1620-2700 mg/day
28kg1680-2800 mg/day
29kg1740-2900 mg/day
30kg1800-3000 mg/day
31kg1860-3100 mg/day
32kg1920-3200 mg/day
33kg1980-3300 mg/day
34kg2040-3400 mg/day
35kg2100-3500 mg/day
36kg2160-3600 mg/day
37kg2220-3700 mg/day
38kg2280-3800 mg/day
39kg2340-3900 mg/day
40kg2400-4000 mg/day
41kg2460-4100 mg/day
42kg2520-4200 mg/day
43kg2580-4300 mg/day
44kg2640-4400 mg/day
45kg2700-4500 mg/day
46kg2760-4600 mg/day
47kg2820-4700 mg/day
48kg2880-4800 mg/day
49kg2940-4900 mg/day
50kg3000-5000 mg/day
Dose source

Acute rheumatic fever without carditis - disease-level clinical article (acute-rheumatic-fever-without-carditis-clinical.txt)

Why

Traditional anti-inflammatory therapy for arthritis in acute rheumatic fever.

Cautions
  • Risk of Reye syndrome in children and adolescents; requires monitoring of salicylate levels and GI tolerance.
  • Gastroprotection recommended during high-dose therapy.
Egyptian brands
Egyptian brandManufacturerIndicative price
ASPOCID 300 MG 200 TABS.CID80.00 EGP (0.40/unit)
AGGREX 75MG 60 TABS.RAMEDA33.00 EGP (0.55/unit)
ASPOCID 75MG 20 TAB.CID22.00 EGP (1.10/unit)
ECOPRIN 325MG 10 ENTERIC COATED TAB.SIGMA5.00 EGP
RIVO 75 MG 30 CHEW. TABS.ARAB DRUG COMPANY (ADCO)21.00 EGP
ASPRICARLO 81MG 30 CHEWABLE TABS.EUROPEAN EGYPTIAN PHARM. IND.45.00 EGP
ASPIRIN PROTECT 100 MG 30 GASTRO-RESISTANT TABS.MEMPHIS > BAYER BITTERFELD GMBH-GERMANY78.00 EGP
JUSPRIN 81 MG 60 E.C.TABS.FUTURE PHARMACEUTICAL INDUSTRIES (FPI) > JULPHAR81.00 EGP

SECONDARY PROPHYLAXIS

4

PENICILLIN G BENZATHINE

Secondary prophylaxis

1st line

Forminjection

Adult dose and duration

IM: 1.2 million units once every 21 to 28 days x 5 years or until age 21

Paediatric dose
Dose by age
≤27 kg:600,000 units every 3 to 4 weeks. >27 kg: 1.2 million units every 3 to 4 weeks.
Dose source

Egyptian National Drug Formulary - Antimicrobial 2023

Why

Intramuscular penicillin G benzathine secondary prophylaxis prevents recurrent Group A streptococcal infection and recurrent attacks of rheumatic fever.

Cautions
  • Hypersensitivity to penicillin(s) or any component of the formulation
  • Do not administer IV, intra-arterially, or SubQ. inadvertent IV administration has resulted in thrombosis, severe neurovascular damage, cardiac arrest, and death.
Egyptian brands
Egyptian brandManufacturerIndicative price
HAYA BENZ-R 1.2 M.I.U. VIAL FOR I.M INJ.SEDICO > HAYA PHARM-EGYPT5.06 EGP
PENICID LA 1 200 000 UNITS VIALCID6.50 EGP
BENZACILLIN 1.2 M.I.U.FOR I.M.INJ VIAL.EL NASR7.00 EGP
RETARPEN 1.2 M.I.U. VIALSANDOZ > OCTOBER PHARMA10.50 EGP
LASTIPEN 1 200 000 IU VIALMISR12.00 EGP
BENZABIOTIC 1.2 M.I.U. I.M. VIAL.SEDICO16.00 EGP
DEPO-PEN 1.2 MIU VIAL.MUP25.00 EGP
PENCILONG (PENCITARD) 1200000 I.U./VIALNCPC NORTH BEST CO > ACDIMA INTERNATIONAL TRADING25.00 EGP

IF ASPIRIN OR AN NSAID CANNOT BE USED

5

PREDNISOLONE

If aspirin or an NSAID cannot be used

2nd line

Strength5 mg

Formoral.solid

Adult dose and duration

5 to 60 mg/day as a single daily dose or in 2 to 4 divided doses, tapered

Paediatric dose

The ENDF prednisolone monograph gives no paediatric figure for this indication, so none is stated here. Acute rheumatic fever is largely a childhood disease - refer.

Dose source

Egyptian National Drug Formulary - Endocrine System 2024 (prednisolone monograph)

Why

The disease article gives a glucocorticoid as the option when the patient cannot take aspirin or an NSAID; the card previously offered only those two.

Cautions
  • Abrupt withdrawal is not recommended, particularly with doses of 40 mg or more or 3 weeks of treatment or more.
  • The dose should be gradually decreased to the lowest dose that maintains an adequate clinical response.
  • No paediatric dose is stated in the ENDF for this use, and this is a predominantly paediatric condition - refer rather than extrapolate.
Egyptian brands
Egyptian brandManufacturerIndicative price
HOSTACORTIN H 5MG 30 TAB.SANOFI12.00 EGP (0.40/unit)
PREDNISOLONE 5 MG 20 TABS.ARAB DRUG COMPANY (ADCO)24.00 EGP (1.20/unit)
PREDILONE 5MG 10 TAB. (25 STRIPS PACK)KAHIRA250.00 EGP (25.00/unit)
EPICOPRED 5 MG 30 ORODISPERSIBLE TABS.EIPICO69.00 EGP
PREDNISOLONE-EVA 5 MG 30 ORODISPERSIBLE TABS.EVA PHARMA79.50 EGP
DISPRELONE-OD 5 MG 30 ORODISPERSABLE TABS.ANDALOUS PHARMA84.00 EGP
SOLUPRED ORO 5 MG 30 ORODISPERSIBLE TABS.SANOFI WINTHROP > SANOFI84.00 EGP
ACETASEE 1% EYE DROPS (SUSP.) 5 ML? strength differs? different route - not oral solidRAMEDA7.50 EGP
PREDNIS 5MG/5ML SYRUP 100 ML? strength differs? different route - not oral solidPHAROPHARMA9.50 EGP

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.